Weight Loss

weight loss injections near me Richmond VA

Moke Aesthetics Weight Loss Programs

Semaglutide (also known as Ozempic & Wegovy)  

  • 3 month program, self injections: $1,500 paid in full  

  • 3 month program, in-office injections: $500 paid per month

Tirzepatide (also known as Mounjaro)  

  • 3 month program, self injections: $1,500 paid in full  

  • 3 month program, in-office injections: $500 paid per month

Labs required for enrollment: complete blood count (CBC), comprehensive metabolic panel (CMP), lipid panel, A1c, lipase, thyroid panel, negative pregnancy test (blood test or OTC urine test)  

WEIGHT LOSS
FAQ

  • Semaglutide is a peptide medication used for weight loss. It works by mimicking the action of a naturally occurring hormone called GLP-1 (glucagon-like peptide-1). GLP-1 is produced in the intestine and released in response to food intake. It has several effects that contribute to weight loss:

    Appetite Suppression: Semaglutide helps reduce appetite by acting on the brain’s appetite control centers. This leads to a decreased desire for food and a feeling of fullness.

    Slowed Gastric Emptying: It slows down the emptying of the stomach, which prolongs the feeling of fullness after a meal, making people eat less.

    Blood Sugar Control: Semaglutide helps regulate blood sugar levels by stimulating the release of insulin only when needed, preventing overeating due to blood sugar spikes and crashes.

    Reduced Caloric Intake: By reducing hunger and food cravings, it helps individuals consume fewer calories, which is essential for weight loss.

    Increased Energy Expenditure: Semaglutide may also enhance energy expenditure, which can contribute to weight loss.

    Semaglutide is typically used as part of a comprehensive weight management program, including a reduced-calorie diet and increased physical activity. It’s not a stand-alone solution and should be prescribed and supervised by a healthcare provider.

  • Semaglutide can have an impact on hunger and appetite. Several studies have shown that semaglutide is associated with reduced hunger and food cravings, as well as better control of eating.

  • Neither medication is categorically “better,” as their efficacy can greatly depend on individual patient factors. Both semaglutide and tirzepatide are GLP-1 medications that can be prescribed to aid in weight loss. Recent studies suggest that tirzepatide may lead to slightly greater weight loss than semaglutide.

  • Studies show an average of 10-15% weight loss from overall body weight. The exact amount of weight you can lose with GLP-1 medications can vary from person to person and depends on a variety of factors such as diet, exercise, and individual response to the medication.

  • The duration for taking semaglutide for weight loss can vary. Most often, semaglutide is prescribed for 12 weeks as part of a weight loss program. During this time, patients receive regular injections of semaglutide and follow a comprehensive weight management plan, which includes dietary changes and increased physical activity. The exact duration may be determined by your healthcare provider based on your individual needs and progress.

    Semaglutide is not a lifelong treatment for weight loss. After the initial treatment period, your healthcare provider will assess your progress and determine whether further treatment is necessary or if you can transition to other maintenance strategies to sustain your weight loss.

  • The most commonly reported symptoms are gastrointestinal symptoms.

    Nausea: Some patients report feeling nauseated, especially when first starting the medication. This side effect typically decreases over time as the body gets used to the medication.

    Diarrhea: Some users may experience loose stools or frequent bowel movements, which can be inconvenient and sometimes dehydrating.

    Constipation: Contrary to diarrhea, some patients might find it hard to have regular bowel movements. Drinking more water and increasing fiber intake can aid in alleviating this side effect.

    Bloating: This refers to a feeling of fullness in the stomach, often accompanied by a noticeable distension of the abdomen. It might be temporary, but if persistent, it’s recommended to consult with a healthcare provider.

  • GLP-1 medication contraindications include a personal or family history of thyroid cancer, as well as a personal history of pancreatitis.

Where science elevates beauty: Aesthetic and wellness treatments redefined.